269 related articles for article (PubMed ID: 12143193)
1. Long-term survival of a patient with primary papillary serous carcinoma of the peritoneum treated by subtotal peritonectomy plus intraoperative chemohyperthermia.
Ajisaka H; Yonemura Y; Bando E; Fushida S; Nishimura G; Miwa K
Hepatogastroenterology; 2002; 49(46):1027-9. PubMed ID: 12143193
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].
Minicozzi A; Borzellino G; Momo EN; Segattini C; Pitoni F; Steccanella F; De Manzoni G
Ann Ital Chir; 2008; 79(4):231-9. PubMed ID: 19093624
[TBL] [Abstract][Full Text] [Related]
3. [Peritonectomy and intraperitoneal chemotherapy--new methods in multi-modality therapy of peritoneal carcinosis].
Jähne J; Piso P
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1435-7. PubMed ID: 9931904
[TBL] [Abstract][Full Text] [Related]
4. Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion.
Yonemura Y; Kawamura T; Bandou E; Takahashi S; Sawa T; Matsuki N
Br J Surg; 2005 Mar; 92(3):370-5. PubMed ID: 15739249
[TBL] [Abstract][Full Text] [Related]
5. Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Nonaka D; Oliva GD; Laterza B; Deraco M
Ann Surg Oncol; 2007 Oct; 14(10):2790-7. PubMed ID: 17661150
[TBL] [Abstract][Full Text] [Related]
6. Peritonectomy and hyperthermic antiblastic perfusion in the treatment of peritoneal carcinomatosis.
Cavaliere F; Di Filippo F; Botti C; Cosimelli M; Giannarelli D; Aloe L; Arcuri E; Aromatario C; Consolo S; Callopoli A; Laurenzi L; Tedesco M; Di Angelo P; Giunta S; Cavaliere R
Eur J Surg Oncol; 2000 Aug; 26(5):486-91. PubMed ID: 11016471
[TBL] [Abstract][Full Text] [Related]
7. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Nonaka D; Langer M; Andreola S; Favaro M; Gavazzi C; Laterza B; Deraco M
Ann Surg Oncol; 2008 Feb; 15(2):526-34. PubMed ID: 18043976
[TBL] [Abstract][Full Text] [Related]
8. The integrated treatment of peritoneal carcinomatosis. A preliminary experience.
Cavaliere F; Di Filippo F; Cosimelli M; Aloe L; Arcuri E; Anzà M; Callopoli A; Di Lauro L; Morace E; Botti C; Natoli S; Tedesco M; Giunta S; Cavaliere R
J Exp Clin Cancer Res; 1999 Jun; 18(2):151-8. PubMed ID: 10464701
[TBL] [Abstract][Full Text] [Related]
9. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
Verwaal VJ; Bruin S; Boot H; van Slooten G; van Tinteren H
Ann Surg Oncol; 2008 Sep; 15(9):2426-32. PubMed ID: 18521686
[TBL] [Abstract][Full Text] [Related]
10. 120 peritoneal carcinomatoses from colorectal cancer treated with peritonectomy and intra-abdominal chemohyperthermia: a S.I.T.I.L.O. multicentric study.
Cavaliere F; Valle M; De Simone M; Deraco M; Rossi CR; Di Filippo F; Verzi S; Giannarelli D; Perri P; Pilati PL; Vaira M; Di Filippo S; Garofalo A
In Vivo; 2006; 20(6A):747-50. PubMed ID: 17203760
[TBL] [Abstract][Full Text] [Related]
11. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
Vaira M; Cioppa T; DE Marco G; Bing C; D'Amico S; D'Alessandro M; Fiorentini G; DE Simone M
In Vivo; 2009; 23(4):639-44. PubMed ID: 19567401
[TBL] [Abstract][Full Text] [Related]
12. [The Czech experience in peritonectomy and hyperthermic perioperative cytostatic lavage in the treatment of peritoneal malignancy].
Antos F; Serclova Z; Gilbert Z; Skala M; Vitek P
Zentralbl Chir; 2004 Apr; 129(2):153-6. PubMed ID: 15106050
[TBL] [Abstract][Full Text] [Related]
13. [Peritoneal carcinosis in appendiceal carcinoma--at what price can the prognosis be improved?].
Piso P; Werner U; Bektas H; Kubicka S; Manns MP; Klempnauer J
Dtsch Med Wochenschr; 2000 Oct; 125(43):1283-7. PubMed ID: 11098226
[TBL] [Abstract][Full Text] [Related]
14. Cytoreductive surgery associated to hyperthermic intraperitoneal chemoperfusion for desmoplastic round small cell tumor with peritoneal carcinomatosis in young patients.
Msika S; Gruden E; Sarnacki S; Orbach D; Philippe-Chomette P; Castel B; Sabaté JM; Flamant Y; Kianmanesh R
J Pediatr Surg; 2010 Aug; 45(8):1617-21. PubMed ID: 20713209
[TBL] [Abstract][Full Text] [Related]
15. Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei.
Witkamp AJ; de Bree E; Kaag MM; van Slooten GW; van Coevorden F; Zoetmulder FA
Br J Surg; 2001 Mar; 88(3):458-63. PubMed ID: 11260116
[TBL] [Abstract][Full Text] [Related]
16. Prognosis of stage III or IV primary peritoneal serous papillary carcinoma.
Dubernard G; Morice P; Rey A; Camatte S; Fourchotte V; Thoury A; Pomel C; Pautier P; Lhommé C; Duvillard P; Castaigne D
Eur J Surg Oncol; 2004 Nov; 30(9):976-81. PubMed ID: 15498644
[TBL] [Abstract][Full Text] [Related]
17. Ten years experience in the treatment of pseudomyxoma peritonei by cytoreduction, peritonectomy and semi-closed hyperthermic antiblastic peritoneal perfusion.
De Simone M; Vaira M; Caponi A; Ciaccio B; Fiorentini G; Turrisi G; Ferri L; Buti G
In Vivo; 2006; 20(6A):725-7. PubMed ID: 17203755
[TBL] [Abstract][Full Text] [Related]
18. Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary.
Bloss JD; Liao SY; Buller RE; Manetta A; Berman ML; McMeekin S; Bloss LP; DiSaia PJ
Gynecol Oncol; 1993 Sep; 50(3):347-51. PubMed ID: 8406199
[TBL] [Abstract][Full Text] [Related]
19. Radical surgery-peritonectomy and intraoperative intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis in recurrent or primary ovarian cancer.
Rufián S; Muñoz-Casares FC; Briceño J; Díaz CJ; Rubio MJ; Ortega R; Ciria R; Morillo M; Aranda E; Muntané J; Pera C
J Surg Oncol; 2006 Sep; 94(4):316-24. PubMed ID: 16917864
[TBL] [Abstract][Full Text] [Related]
20. Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion.
Deraco M; Nonaka D; Baratti D; Casali P; Rosai J; Younan R; Salvatore A; Cabras Ad AD; Kusamura S
Ann Surg Oncol; 2006 Feb; 13(2):229-37. PubMed ID: 16444562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
